Ontology highlight
ABSTRACT:
SUBMITTER: Sada M
PROVIDER: S-EPMC7589801 | biostudies-literature | 2020 Oct
REPOSITORIES: biostudies-literature
Sada Mitsuru M Saraya Takeshi T Ishii Haruyuki H Okayama Kaori K Hayashi Yuriko Y Tsugawa Takeshi T Nishina Atsuyoshi A Murakami Koichi K Kuroda Makoto M Ryo Akihide A Kimura Hirokazu H
Microorganisms 20201020 10
Favipiravir was initially developed as an antiviral drug against influenza and is currently used in clinical trials against severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection (COVID-19). This agent is presumably involved in RNA chain termination during influenza virus replication, although the molecular interactions underlying its potential impact on the coronaviruses including SARS-CoV-2, SARS-CoV, and Middle East respiratory syndrome coronavirus (MERS-CoV) remain unclear. W ...[more]